Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Guangdong Association of Clinical Trials
Guangdong Association of Clinical Trials
Novartis
Novartis
Pfizer
The Affiliated Hospital of Qingdao University
AstraZeneca
On Target Laboratories, LLC
Shanghai Pulmonary Hospital, Shanghai, China
Charite University, Berlin, Germany
George Washington University
Vanderbilt-Ingram Cancer Center
Tongji Hospital
Institut Paoli-Calmettes
Fujian Cancer Hospital
Pfizer
Groupe Francais De Pneumo-Cancerologie
AstraZeneca
Korea University Guro Hospital
Pharmacosmos A/S
Merck Sharp & Dohme LLC
China Medical University, China
Peking Union Medical College Hospital